According to United Therapeutics's latest financial reports the company's current revenue (TTM) is $2.32 B. In 2022 the company made a revenue of $1.93 B an increase over the years 2021 revenue that were of $1.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.32 B | 20.2% |
2022 | $1.93 B | 14.88% |
2021 | $1.68 B | 13.63% |
2020 | $1.48 B | 2.38% |
2019 | $1.44 B | -11% |
2018 | $1.62 B | -5.65% |
2017 | $1.72 B | 7.91% |
2016 | $1.59 B | 9.08% |
2015 | $1.46 B | 13.76% |
2014 | $1.28 B | 15.36% |
2013 | $1.11 B | 21.93% |
2012 | $0.91 B | 23.26% |
2011 | $0.74 B | 24.14% |
2010 | $0.59 B | 61.86% |
2009 | $0.36 B | 31.39% |
2008 | $0.28 B | 33.45% |
2007 | $0.21 B | 32.14% |
2006 | $0.15 B | 37.71% |
2005 | $0.11 B | 57.51% |
2004 | $73.59 M | 37.96% |
2003 | $53.34 M | 77.09% |
2002 | $30.12 M | 425.5% |
2001 | $5.73 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 2,413.30% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 1,366.13% | ๐บ๐ธ USA |
Baxter BAX | $14.94 B | 542.28% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | 1,064.98% | ๐บ๐ธ USA |
Cardinal Health CAH | $216.14 B | 9,186.70% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 1,526.17% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | $7.53 M | -99.68% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 580.82% | ๐ฎ๐ฑ Israel |